{"id":"W2981815608","doi":"10.1038/s41571-019-0287-0","title":"Imatinib and the long tail of targeted drug development","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Imatinib; Medicine; Drug; Drug development; Imatinib mesylate; Anticancer drug; Targeted therapy; Cancer; Pharmacology; Intensive care medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.007264805,0.000717829,0.01268785,0.0001311692,0.00005937874,0.000008626169,0.0004899692,0.002588314,0.0002844782],"category_scores_gemma":[0.006234694,0.0003350072,0.001896561,0.0003997509,0.0006481679,0.00003345837,0.0003808997,0.004606585,0.0005198707],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009763167,"about_ca_system_score_gemma":0.005781183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006626045,"about_ca_topic_score_gemma":0.0000230939,"domain_scores_codex":[0.9904787,0.002877496,0.004920532,0.0008874845,0.0004048472,0.0004309213],"domain_scores_gemma":[0.9873564,0.007520226,0.003470275,0.001216264,0.0001773282,0.0002595004],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000142365,0.0002690531,0.00006935351,0.03953043,0.0009481597,0.00004553934,0.00004571157,6.700266e-9,1.303669e-8,0.0001360185,0.008975205,0.9498382],"study_design_scores_gemma":[0.006241519,0.0002747581,0.000160835,0.0258558,0.006521301,0.0002506834,0.000003842006,0.000001665812,2.760873e-7,0.00001208005,0.9604292,0.0002480332],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001918512,0.9882828,0.000004298373,0.0005430732,0.001178258,0.006974711,0.0000142805,0.0000265068,0.002956899],"genre_scores_gemma":[0.000007194832,0.9896601,0.004737434,0.001241483,0.0004919267,0.0003825542,0.0002838308,0.00007040989,0.003125009],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.951454,"threshold_uncertainty_score":0.9999102,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1246172481759774,"score_gpt":0.4865693124488298,"score_spread":0.3619520642728525,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}